BIOVALLEY
Kunming
About BIOVALLEY
Biovalley manufactures and sells the breviscapine series of drugs. They provide injections, capsules, tablets, dripping pills, erigeron capsules, and soft capsules. They provide solutions for ischemic cardiovascular and cerebrovascular diseases, stroke sequelae, and coronary heart disease treatment.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Total funding: $22.3M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2016)
- Ticker: neeq:833266
- Website: biovalley.cn
- Phone: 0871-65016111
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/biovalley-2250614 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.